Intrinsic Value of S&P & Nasdaq Contact Us

Adlai Nortye Ltd. ANL NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • KY • USD

SharesGrow Score
42/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$16.00
+17.5%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Adlai Nortye Ltd. (ANL) has a negative trailing P/E of -2.3, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -42.96%.

Criteria proven by this page:

  • VALUE (75/100, Pass) — analyst target implies upside (+17.5%).
  • Trailing Earnings Yield -42.96% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.
  • Analyst consensus target $16.00 (+17.5% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 41/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
42/100
SG Score
View full scorecard →
VALUE
75/100
Price-to-Earnings & upside
Proven by this page
FUTURE
94/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
MOAT
35/100
→ Income
GROWTH
15/100
→ Income
INCOME
N/A
No coverage

Valuation Snapshot — ANL

Valuation Multiples
P/E (TTM)-2.3
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio4.74
P/S Ratio0.00
EV/EBITDA-6.7
Per Share Data
EPS (TTM)$-4.88
Book Value / Share$2.39
Revenue / Share$0.00
FCF / Share$-4.89
Yields & Fair Value
Earnings Yield-42.96%
Dividend Yield0.00%
Analyst Target$16.00 (+17.5%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2019 -7.1 0.00 -1.83 0.00 -
2020 -2.0 -0.01 -0.97 0.00 -
2021 -2.2 0.18 -0.69 2.78 -
2022 -2.2 -0.53 -0.53 0.00 -
2023 -0.6 0.00 0.77 12.24 -
2024 -0.6 0.01 1.12 0.00 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2019 $-2.10 $0.00 $-17.83M -
2020 $-7.63 $0.00 $-63.38M -
2021 $-6.67 $45.73M $-56.68M -124%
2022 $-6.92 $0.00 $-58.79M -
2023 $-15.42 $5M $-104.87M -2099.2%
2024 $-4.89 $0.00 $-51.9M -

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.23 $-0.26 – $-0.18 $6.73M $6.73M – $6.73M 2
2027 $-0.36 $-0.36 – $-0.36 $100K $100K – $100K 1
2028 $-0.60 $-0.60 – $-0.60 $200K $200K – $200K 1
2029 $-1.28 $-1.28 – $-1.28 $200K $200K – $200K 1
2030 $-1.40 $-1.40 – $-1.40 $80.6M $80.6M – $80.6M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message